Loading
Latest filing published 15 Jan 2026 for CANbridge Pharmaceuticals Inc. - B. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Geraghty James Arthur on record concern CANbridge Pharmaceuticals Inc. - B. In total, 3 filings cover trades dated from 10 December 2021 to 12 January 2026.
The open-market record is one-sided, with 1 purchase and not one sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 1 purchase and no sales.
Most recently, on 15 January 2026, the filings show an open-market purchase in CANbridge Pharmaceuticals Inc. - B. Typically, a trade is published a median of 6 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations